Patents Assigned to ICN Pharmaceuticals
  • Patent number: 4021556
    Abstract: Compounds of the following structure are disclosed which are effective inhibitors of the enzyme xanthine oxidase: ##STR1## R is an aromatic or substituted aromatic nucleus such as phenyl, R.sub.1 is H, an alkali metal or ammonium, and R.sub.2 is H or OR.sub.1.
    Type: Grant
    Filed: November 17, 1975
    Date of Patent: May 3, 1977
    Assignee: ICN Pharmaceuticals, Inc.
    Inventors: Robert H. Springer, Darrell E. O'Brien, Lionel N. Simon
  • Patent number: 3991078
    Abstract: Antiviral 1-(G)-1,2,4-triazole carboxamides, thiocarboxamides and carboxamidines wherein G is an acid labile hydrocarbon moiety, e.g., 1-(.alpha.-alkoxyalkyl), are prepared by, e.g., the acid-catalyzed addition reaction of appropriately substituted 1,2,4-triazole and an .alpha.,.beta.-unsaturated ether.
    Type: Grant
    Filed: March 18, 1974
    Date of Patent: November 9, 1976
    Assignee: ICN Pharmaceuticals, Inc.
    Inventors: Joseph T. Witkowski, Roland K. Robins
  • Patent number: 3984396
    Abstract: Phosphate and carboxylic acid esters of 1-(.beta.-D-ribofuranosyl)-1,2,4-triazoles are prepared by a variety of methods and their antiviral activity reported.
    Type: Grant
    Filed: March 18, 1974
    Date of Patent: October 5, 1976
    Assignee: ICN Pharmaceuticals, Inc.
    Inventors: Joseph T. Witkowski, Roland K. Robins
  • Patent number: 3976545
    Abstract: The use of 1,2,4-triazole-3-carboxamide and 1,2,4-triazole-3-thiocarboxamide and physiologically compatible salts thereof as antiviral agents is disclosed. A process for synthesizing 1-.beta.-D-ribofuranosyl-1,2,4-triazole-3-carboxamide is also disclosed.
    Type: Grant
    Filed: September 29, 1975
    Date of Patent: August 24, 1976
    Assignee: ICN Pharmaceuticals, Inc.
    Inventors: Joseph T. Witkowski, Roland K. Robins
  • Patent number: 3968103
    Abstract: Novel substituted 1,2,3-triazole nucleosides such as 4-R'-2-.beta.-D-ribofuranosyl-1,2,3-triazole wherein R' is a nitro, carboxylic acid ester, cyano, carboxamide or thiocarboxamide group are prepared by a procedure entailing fusion of an appropriately substituted 1,2,3-triazole with a tetra-0-acyl blocked ribofuranose. The resulting compounds exhibit significant antimicrobial activity in in vitro testing or are useful in preparing compounds which exhibit such activity.
    Type: Grant
    Filed: September 28, 1972
    Date of Patent: July 6, 1976
    Assignee: ICN Pharmaceuticals, Inc.
    Inventors: Roland K. Robins, Joseph T. Witkowski
  • Patent number: 3968101
    Abstract: Novel compounds of the general formula ##SPC1##Wherein X is H or NH.sub.2 ; R' is C.sub.1 to C.sub.8 alkyl, C.sub.1 to C.sub.8 substituted alkyl, benzyl, C.sub.1 to C.sub.8 acyl, benzoyl, carbamoyl, are disclosed as well as a novel free radial alkylation and acylation process for making such compounds. The compounds of the invention display activity comparable to or superior to their naturally occurring analogue while resisting phosphodiesterase degradation. In some cases the compounds of this invention actually inhibit enzymatic degradation of the natural analogue.
    Type: Grant
    Filed: December 20, 1974
    Date of Patent: July 6, 1976
    Assignee: ICN Pharmaceuticals, Inc.
    Inventors: Leon F. Christensen, Roland K. Robins
  • Patent number: 3948885
    Abstract: A 5-hydroxy-1,2,3-triazole-4-carboxamide nucleoside, related to the C-nucleoside pyrazomycin, is facilely synthesized by condensation of acyl-blocked ribofuranose with trimethylsilylated 5-hydroxy-1,2,3-triazole-4-carboxamide or, alternatively, by cycloaddition of suitably blocked .beta.-D-ribofuranosyl azide and the anion of ethyl malonamate, and demonstrated to exhibit antiviral properties. The triazole precursor of the former route, as well as certain of its novel salts, are also disclosed as potential antiviral agents.
    Type: Grant
    Filed: March 19, 1973
    Date of Patent: April 6, 1976
    Assignee: ICN Pharmaceuticals, Inc.
    Inventors: Joseph T. Witkowski, Roland K. Robins, Frank A. Lehmkuhl
  • Patent number: 3948886
    Abstract: Described herein are novel 6-alkylthio and 6-arylalkylthio purine 3',5' cyclic nucleotides variously exhibiting adenyl cyclase and (in animal studies) tumor inhibitory properties, interferon potentiation, antiviral activity, and the ability to activate adenosine 3',5'-cyclic phosphate-dependent protein kinase while enjoying resistance to phosphodiesterase hydrolysis superior to that of its naturally occuring analog. The compounds are obtained by alkylation of the corresponding 6-thio nucleotide, which is in turn provided by a novel synthetic route.
    Type: Grant
    Filed: June 8, 1973
    Date of Patent: April 6, 1976
    Assignee: ICN Pharmaceuticals, Inc.
    Inventors: Dennis A. Shuman, Rich B. Meyer, Jr., Roland K. Robins